definite stent thrombosis

Related by string. * Definite . definites . DEFINITE : definite crowd pleaser . Definite Article . Definite Interest . Time Definite . definite absentees / stenting . Stents . Stenting . Stent . stented : drug coated stents . stents inserted . Endeavor stent . drug coated stent / Thrombosis : deep vein thrombosis . Deep vein thrombosis . superficial vein thrombosis . stent thrombosis * *

Related by context. Frequent words. (Click for all words.) 72 virologic failure 71 thromboembolic events 70 mg kg dose 68 myocardial infarctions 68 virologic response 68 composite endpoint 68 discontinuations due 68 vertebral fracture 68 thromboembolism 68 thrombotic events 67 laboratory abnormalities 67 myocardial infarction MI 66 cerebrovascular events 66 annualized relapse 66 CYPHER ® Stent 66 nonresponders 66 nonsignificant 66 LVEF 66 cytogenetic response 65 lipid lowering drugs 65 coronary revascularization 65 events SAEs 65 cardiovascular hospitalization 65 tumor recurrence 65 P = .# 65 myocardial infarction stroke 64 events AEs 64 seroconversion 64 confidence interval #.#-#.# 64 sustained virologic response 64 unfractionated heparin 64 target lesion revascularization 64 mg BID 64 fondaparinux 64 HbA1c levels 64 QTc 63 adalimumab 63 stent thrombosis 63 neoadjuvant 63 microalbuminuria 63 subgroup analyzes 63 DAS# [002] 63 febrile neutropenia 63 serum concentrations 63 peginterferon alfa 2a 63 intracerebral hemorrhage 63 mg QD 63 leukopenia 63 achieved statistical significance 63 secondary efficacy endpoints 63 renal dysfunction 63 venous thrombosis 63 postoperative complications 63 venous thromboembolism 63 evaluable 63 prespecified 63 confidence interval CI 63 target vessel revascularization 63 vertebral fractures 62 neoadjuvant therapy 62 hypercalcemia 62 ADHF 62 Median survival 62 median PFS 62 SAEs 62 TORISEL 62 noninferiority 62 Adverse events 62 distant metastases 62 CMV disease 62 abciximab 62 enoxaparin 62 hypomagnesemia 62 endarterectomy 62 FOLFIRI 62 discontinuations 61 stable angina 61 % CI #.#-#.# [006] 61 infarct size 61 lymph node involvement 61 nab paclitaxel 61 treatment emergent adverse 61 PCa 61 dual antiplatelet therapy 61 TAXUS stent 61 myocardial ischemia 61 STEMI patients 61 decitabine 61 stent implantation 61 cardiogenic shock 61 CMV infection 61 placebo p = 61 fasting insulin 61 tumor lysis syndrome 61 plus methotrexate 61 VTE 61 epithelial ovarian cancer 61 systolic BP 61 comorbid conditions 61 eGFR 61 plus gemcitabine

Back to home page